Isolation of peptide transport system-6 from brain endothelial cells: therapeutic effects with antisense inhibition in Alzheimer and stroke models.
about
Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in strokeTransporters at CNS barrier sites: obstacles or opportunities for drug delivery?Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injuryNeurovascular pathways to neurodegeneration in Alzheimer's disease and other disordersCharacteristics of compounds that cross the blood-brain barrierTesting the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognitionSystemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma.Mouse models of neurological disorders: a view from the blood-brain barrier.Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases.Transcriptomics and proteomics analyses of the PACAP38 influenced ischemic brain in permanent middle cerebral artery occlusion model mice.Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differencesAge-related decline of autocrine pituitary adenylate cyclase-activating polypeptide impairs angiogenic capacity of rat cerebromicrovascular endothelial cells.Unraveling the ischemic brain transcriptome in a permanent middle cerebral artery occlusion mouse model by DNA microarray analysis.Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditionsMethod parameters' impact on mortality and variability in mouse stroke experiments: a meta-analysis.Targeted drug delivery to treat pain and cerebral hypoxiaC-terminal amidation of PACAP-38 and PACAP-27 is dispensable for biological activity at the PAC1 receptorNovel and emerging strategies in drug delivery for overcoming the blood-brain barrier.Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier.Delivery of therapeutic peptides and proteins to the CNS.Anatomy and physiology of the blood-brain barrier.Targeted delivery of growth factors in ischemic stroke animal models.Pharmacomodulation of microRNA Expression in Neurocognitive Diseases: Obstacles and Future Opportunities.PACAP enhances barrier properties of cerebral microvessels.PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.Intranasal administration of PACAP: uptake by brain and regional brain targeting with cyclodextrins.Pituitary adenylate cyclase-activating polypeptide (PACAP) protects against mitoxantrone-induced cardiac injury in mice.Getting Drugs Across Biological Barriers.Drug transport into the central nervous system: using newer findings about the blood-brain barriers.Protective effects of PACAP in ischemia.Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine.Comprehensive evaluation of blood-brain barrier-forming micro-vasculatures: Reference and marker genes with cellular composition.
P2860
Q26864317-5F18CDBB-AD5B-4788-98ED-7091F3E431ECQ27690256-EB12B6C7-AE24-4AFB-BD73-76EE4E137F7FQ28088708-4C4F5295-F042-4CF8-8449-F5CD1E517E80Q29615839-DEA1D97C-2081-4599-B3FD-EC18CB07A0B7Q33469828-60603F81-24C8-4C69-A077-E3DB792EDD0CQ33576221-2E1A0D4B-E55E-4FB8-8BA8-5ECEEF3267FCQ33779928-4E84D765-ECDE-421D-A39A-207937A1332FQ33938994-E42B34F4-06E9-4BDB-865A-E3C62FE431B1Q34179881-FCD1A883-D2FD-461F-9E63-240A4352EAAAQ34486611-8EAA2AFE-8CCB-4123-A58E-B89468AFBBB1Q34608061-A817D6C3-2AE6-4B13-A964-236FA1397729Q35661804-3C949A7A-43D8-4604-8FD7-50DE659851EBQ35794591-9DBC8DE5-910F-425B-87F7-92CBBE17FFA5Q35855634-81F55507-0653-4414-ABA9-6F80543CBD23Q35887816-77D1F355-0B39-4A74-8B43-44483AC344EEQ36579398-7D694533-BE6E-4B72-9C57-D0CA6609D821Q36591611-55EC1FC1-54A4-46A2-A54F-6036C612D624Q36828479-3118050D-5D00-4964-88A5-4BDC4937736CQ37855817-BEBF68D8-27BE-406E-84F1-76BF71A6D738Q37971834-8ADA2863-1D6F-4FA6-A8AD-C7020D912BA6Q38259307-3386A890-DA93-477D-8C50-5A131E29D0A8Q38355390-DD07506C-E81E-4F2E-8551-6CEAF4785C1AQ38703863-7CAD60D5-7C4C-4CEE-BE07-2A0B997679C2Q38843518-7299EF7A-BB82-4145-A2B3-23B2F4D5E322Q39016755-DC925CA5-E075-4623-B7C5-F9F29FCE23A4Q39159132-FA5AA1CF-3CF7-44F5-952B-4A9511C935CDQ42274137-FA197FFB-5634-4E09-8148-6DBA54A51D0FQ47694093-21B98E09-FEA8-48DE-B84B-456BBF5D3C11Q48331228-A24F064A-38F6-4F1A-9870-4FFF3C0BBBCEQ48489678-A2EF21F5-91F4-41FC-BFBE-6945CB0B9F4EQ52368754-2202ADA9-D24F-4021-880E-192988BA9942Q55004700-44AA6637-2E0D-4AD9-9559-107DC7C6A1A1Q55008734-F99B0573-0FAB-4C15-AD47-520C1A381D38
P2860
Isolation of peptide transport system-6 from brain endothelial cells: therapeutic effects with antisense inhibition in Alzheimer and stroke models.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Isolation of peptide transport ...... n Alzheimer and stroke models.
@en
type
label
Isolation of peptide transport ...... n Alzheimer and stroke models.
@en
prefLabel
Isolation of peptide transport ...... n Alzheimer and stroke models.
@en
P2093
P2860
P356
P1476
Isolation of peptide transport ...... n Alzheimer and stroke models.
@en
P2093
Dilek Dogrukol-Ak
Hirokazu Ohtaki
Jan S Ryerse
John C Edwards
John E Morley
Michael L Niehoff
Naoko Nonaka
Seiji Shioda
Sulekha Verma
Susan A Farr
P2860
P304
P356
10.1038/JCBFM.2008.131
P577
2008-11-12T00:00:00Z